

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 9.76142413 |
| 2 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 9.33078368 |
| 3 | ATP synthesis coupled proton transport (GO:0015986) | 9.33078368 |
| 4 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 7.81195730 |
| 5 | respiratory electron transport chain (GO:0022904) | 7.46979140 |
| 6 | viral transcription (GO:0019083) | 7.41547000 |
| 7 | electron transport chain (GO:0022900) | 7.30994348 |
| 8 | translational termination (GO:0006415) | 7.12956689 |
| 9 | ribosomal small subunit biogenesis (GO:0042274) | 6.63760752 |
| 10 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 6.36975029 |
| 11 | cotranslational protein targeting to membrane (GO:0006613) | 6.33928083 |
| 12 | protein targeting to ER (GO:0045047) | 6.29589198 |
| 13 | ribosomal small subunit assembly (GO:0000028) | 6.19835760 |
| 14 | translational elongation (GO:0006414) | 6.18310006 |
| 15 | protein localization to endoplasmic reticulum (GO:0070972) | 5.97507548 |
| 16 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 5.96870542 |
| 17 | cellular protein complex disassembly (GO:0043624) | 5.80337008 |
| 18 | viral life cycle (GO:0019058) | 5.75923284 |
| 19 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 5.19030114 |
| 20 | ATP biosynthetic process (GO:0006754) | 5.15183867 |
| 21 | translational initiation (GO:0006413) | 5.14983826 |
| 22 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 5.11116860 |
| 23 | chaperone-mediated protein transport (GO:0072321) | 5.09863852 |
| 24 | protein complex biogenesis (GO:0070271) | 5.03079703 |
| 25 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 4.95633341 |
| 26 | oxidative phosphorylation (GO:0006119) | 4.93977787 |
| 27 | protein neddylation (GO:0045116) | 4.91259132 |
| 28 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 4.90974997 |
| 29 | ribosomal large subunit biogenesis (GO:0042273) | 4.90387957 |
| 30 | protein complex disassembly (GO:0043241) | 4.89443700 |
| 31 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.82673317 |
| 32 | NADH dehydrogenase complex assembly (GO:0010257) | 4.82673317 |
| 33 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.82673317 |
| 34 | mitochondrial respiratory chain complex assembly (GO:0033108) | 4.71483226 |
| 35 | macromolecular complex disassembly (GO:0032984) | 4.69063114 |
| 36 | translation (GO:0006412) | 4.61505722 |
| 37 | hydrogen ion transmembrane transport (GO:1902600) | 4.60838555 |
| 38 | inner mitochondrial membrane organization (GO:0007007) | 4.48274316 |
| 39 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 4.47004154 |
| 40 | maturation of SSU-rRNA (GO:0030490) | 4.41678456 |
| 41 | GTP biosynthetic process (GO:0006183) | 4.27206497 |
| 42 | protein targeting to membrane (GO:0006612) | 4.23770593 |
| 43 | nucleoside triphosphate biosynthetic process (GO:0009142) | 3.98038762 |
| 44 | regulation of mitochondrial translation (GO:0070129) | 3.95222095 |
| 45 | proton transport (GO:0015992) | 3.92540258 |
| 46 | aldehyde catabolic process (GO:0046185) | 3.91171139 |
| 47 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.84458785 |
| 48 | termination of RNA polymerase III transcription (GO:0006386) | 3.84458785 |
| 49 | hydrogen transport (GO:0006818) | 3.84080927 |
| 50 | UTP biosynthetic process (GO:0006228) | 3.81739487 |
| 51 | protein targeting to mitochondrion (GO:0006626) | 3.78672349 |
| 52 | establishment of protein localization to mitochondrion (GO:0072655) | 3.77687612 |
| 53 | proteasome assembly (GO:0043248) | 3.76021829 |
| 54 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.68661876 |
| 55 | establishment of integrated proviral latency (GO:0075713) | 3.65090159 |
| 56 | sequestering of actin monomers (GO:0042989) | 3.64238524 |
| 57 | protein localization to mitochondrion (GO:0070585) | 3.62634983 |
| 58 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.57070726 |
| 59 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.56758144 |
| 60 | purine ribonucleoside monophosphate biosynthetic process (GO:0009168) | 3.55665513 |
| 61 | purine nucleoside monophosphate biosynthetic process (GO:0009127) | 3.55665513 |
| 62 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.55043435 |
| 63 | cellular component biogenesis (GO:0044085) | 3.54261537 |
| 64 | UTP metabolic process (GO:0046051) | 3.53397963 |
| 65 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.52794962 |
| 66 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.49786785 |
| 67 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.47799250 |
| 68 | mitochondrial transport (GO:0006839) | 3.46563087 |
| 69 | RNA catabolic process (GO:0006401) | 3.46502391 |
| 70 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.44318713 |
| 71 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.42454994 |
| 72 | respiratory chain complex IV assembly (GO:0008535) | 3.39200067 |
| 73 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.36736865 |
| 74 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.36422927 |
| 75 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.29426066 |
| 76 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.29426066 |
| 77 | rRNA processing (GO:0006364) | 3.27287636 |
| 78 | cytochrome complex assembly (GO:0017004) | 3.26282219 |
| 79 | chromatin remodeling at centromere (GO:0031055) | 3.26129741 |
| 80 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.25140505 |
| 81 | negative regulation of ligase activity (GO:0051352) | 3.25140505 |
| 82 | DNA deamination (GO:0045006) | 3.23157409 |
| 83 | CENP-A containing nucleosome assembly (GO:0034080) | 3.22347144 |
| 84 | rRNA modification (GO:0000154) | 3.21437403 |
| 85 | mRNA catabolic process (GO:0006402) | 3.21374641 |
| 86 | regulation of oxidative phosphorylation (GO:0002082) | 3.20888650 |
| 87 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.19131048 |
| 88 | establishment of viral latency (GO:0019043) | 3.18966703 |
| 89 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.18804806 |
| 90 | establishment of protein localization to membrane (GO:0090150) | 3.18061268 |
| 91 | cellular ketone body metabolic process (GO:0046950) | 3.17389496 |
| 92 | regulation of cellular respiration (GO:0043457) | 3.15575158 |
| 93 | aerobic respiration (GO:0009060) | 3.14740364 |
| 94 | rRNA metabolic process (GO:0016072) | 3.14169791 |
| 95 | CTP metabolic process (GO:0046036) | 3.13693066 |
| 96 | CTP biosynthetic process (GO:0006241) | 3.13693066 |
| 97 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.13321591 |
| 98 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.13321591 |
| 99 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.12373284 |
| 100 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.10416490 |
| 101 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.09241261 |
| 102 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.09241261 |
| 103 | spliceosomal snRNP assembly (GO:0000387) | 3.08788301 |
| 104 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.08725837 |
| 105 | protein targeting (GO:0006605) | 3.07801218 |
| 106 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.05567371 |
| 107 | cullin deneddylation (GO:0010388) | 3.05180953 |
| 108 | purine nucleoside biosynthetic process (GO:0042451) | 3.04472870 |
| 109 | purine ribonucleoside biosynthetic process (GO:0046129) | 3.04472870 |
| 110 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.03637851 |
| 111 | de novo posttranslational protein folding (GO:0051084) | 3.03621665 |
| 112 | formation of translation preinitiation complex (GO:0001731) | 3.03427342 |
| 113 | ribonucleoside monophosphate biosynthetic process (GO:0009156) | 3.03014293 |
| 114 | de novo protein folding (GO:0006458) | 3.02463587 |
| 115 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.02158783 |
| 116 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.02037748 |
| 117 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.02037748 |
| 118 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.02037748 |
| 119 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.00771714 |
| 120 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.98179725 |
| 121 | nucleoside monophosphate biosynthetic process (GO:0009124) | 2.97950874 |
| 122 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.97898382 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 5.16379146 |
| 2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.45316336 |
| 3 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.38380050 |
| 4 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.37482963 |
| 5 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.16116176 |
| 6 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.95890216 |
| 7 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.66445059 |
| 8 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.57380633 |
| 9 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.48713934 |
| 10 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.48427470 |
| 11 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.44807921 |
| 12 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 3.14472804 |
| 13 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 3.10244701 |
| 14 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 3.05985500 |
| 15 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.88217323 |
| 16 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.86505851 |
| 17 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.71365676 |
| 18 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.70093602 |
| 19 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.60667709 |
| 20 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.44338440 |
| 21 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.33537956 |
| 22 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.29932197 |
| 23 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.27931708 |
| 24 | TTF2_22483619_ChIP-Seq_HELA_Human | 2.26354390 |
| 25 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.26300537 |
| 26 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 2.24453021 |
| 27 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 2.17864703 |
| 28 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.14848706 |
| 29 | * YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.14677956 |
| 30 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.13215446 |
| 31 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.01340094 |
| 32 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.00693978 |
| 33 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.94898092 |
| 34 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.94645334 |
| 35 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.94586521 |
| 36 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.88666204 |
| 37 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.87633596 |
| 38 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.83699995 |
| 39 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.80603248 |
| 40 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.77552330 |
| 41 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.66936996 |
| 42 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.63367103 |
| 43 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.62164815 |
| 44 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.60896300 |
| 45 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.55586915 |
| 46 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.54555210 |
| 47 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.52644056 |
| 48 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.52007347 |
| 49 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.51967597 |
| 50 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.51802082 |
| 51 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.51383874 |
| 52 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43708257 |
| 53 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.38371749 |
| 54 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.37941321 |
| 55 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.37856866 |
| 56 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.36321028 |
| 57 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.36269846 |
| 58 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33490034 |
| 59 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.25674967 |
| 60 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.24655820 |
| 61 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.23446405 |
| 62 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.22364445 |
| 63 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.19754827 |
| 64 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.19583556 |
| 65 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.19461216 |
| 66 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.16731837 |
| 67 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.15314442 |
| 68 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.14520252 |
| 69 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.14122300 |
| 70 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.10231731 |
| 71 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.09532492 |
| 72 | VDR_22108803_ChIP-Seq_LS180_Human | 1.07549439 |
| 73 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.07355373 |
| 74 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.04750268 |
| 75 | EWS_26573619_Chip-Seq_HEK293_Human | 1.03189743 |
| 76 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.02174876 |
| 77 | FUS_26573619_Chip-Seq_HEK293_Human | 1.01780271 |
| 78 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.00020775 |
| 79 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.98730488 |
| 80 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.97827763 |
| 81 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.96605829 |
| 82 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.95874701 |
| 83 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.95757675 |
| 84 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.94491331 |
| 85 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.94135582 |
| 86 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.93271464 |
| 87 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92604804 |
| 88 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.90689049 |
| 89 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.90335844 |
| 90 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.90265183 |
| 91 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.89835047 |
| 92 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.89506565 |
| 93 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.89295050 |
| 94 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.89220341 |
| 95 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.87935768 |
| 96 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.87882318 |
| 97 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.87517569 |
| 98 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.84657201 |
| 99 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.84361125 |
| 100 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.82596039 |
| 101 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.82337794 |
| 102 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.81693229 |
| 103 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.77254821 |
| 104 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.75441994 |
| 105 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.75056736 |
| 106 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.74830385 |
| 107 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.74321756 |
| 108 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.73782385 |
| 109 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.73635566 |
| 110 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.72747750 |
| 111 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.72620162 |
| 112 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.72452262 |
| 113 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.72150336 |
| 114 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.70721047 |
| 115 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.70417416 |
| 116 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.69281629 |
| 117 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.68891995 |
| 118 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.64313433 |
| 119 | * FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.63647327 |
| 120 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.62409135 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009379_abnormal_foot_pigmentation | 6.16554084 |
| 2 | MP0001529_abnormal_vocalization | 3.76727704 |
| 3 | MP0003806_abnormal_nucleotide_metabolis | 3.61576682 |
| 4 | MP0006276_abnormal_autonomic_nervous | 3.50218741 |
| 5 | MP0006036_abnormal_mitochondrial_physio | 3.39677141 |
| 6 | MP0003693_abnormal_embryo_hatching | 3.10049330 |
| 7 | MP0002736_abnormal_nociception_after | 3.08640188 |
| 8 | MP0003186_abnormal_redox_activity | 3.01728364 |
| 9 | MP0006292_abnormal_olfactory_placode | 2.92367290 |
| 10 | MP0008058_abnormal_DNA_repair | 2.90860785 |
| 11 | MP0002735_abnormal_chemical_nociception | 2.79497812 |
| 12 | MP0006035_abnormal_mitochondrial_morpho | 2.77259943 |
| 13 | MP0001968_abnormal_touch/_nociception | 2.68730060 |
| 14 | MP0005360_urolithiasis | 2.35046339 |
| 15 | MP0004957_abnormal_blastocyst_morpholog | 2.34435354 |
| 16 | MP0001905_abnormal_dopamine_level | 2.33874369 |
| 17 | MP0005083_abnormal_biliary_tract | 2.28106289 |
| 18 | MP0002638_abnormal_pupillary_reflex | 2.15179992 |
| 19 | MP0002139_abnormal_hepatobiliary_system | 2.03961295 |
| 20 | MP0002837_dystrophic_cardiac_calcinosis | 1.87160599 |
| 21 | MP0008932_abnormal_embryonic_tissue | 1.83792035 |
| 22 | MP0005636_abnormal_mineral_homeostasis | 1.83643761 |
| 23 | MP0008877_abnormal_DNA_methylation | 1.82007078 |
| 24 | MP0004142_abnormal_muscle_tone | 1.81080999 |
| 25 | MP0001970_abnormal_pain_threshold | 1.80200533 |
| 26 | MP0002733_abnormal_thermal_nociception | 1.75400857 |
| 27 | MP0003880_abnormal_central_pattern | 1.75082991 |
| 28 | MP0008875_abnormal_xenobiotic_pharmacok | 1.73257442 |
| 29 | MP0000372_irregular_coat_pigmentation | 1.72740410 |
| 30 | MP0002751_abnormal_autonomic_nervous | 1.71325556 |
| 31 | MP0003786_premature_aging | 1.71125634 |
| 32 | MP0001984_abnormal_olfaction | 1.67780055 |
| 33 | MP0005084_abnormal_gallbladder_morpholo | 1.66831446 |
| 34 | MP0004147_increased_porphyrin_level | 1.64870669 |
| 35 | MP0002234_abnormal_pharynx_morphology | 1.61219010 |
| 36 | MP0002734_abnormal_mechanical_nocicepti | 1.61188684 |
| 37 | MP0002822_catalepsy | 1.59677773 |
| 38 | MP0010386_abnormal_urinary_bladder | 1.58716553 |
| 39 | MP0000538_abnormal_urinary_bladder | 1.56623552 |
| 40 | MP0001986_abnormal_taste_sensitivity | 1.55935292 |
| 41 | MP0003111_abnormal_nucleus_morphology | 1.55085139 |
| 42 | MP0005408_hypopigmentation | 1.54280013 |
| 43 | MP0001727_abnormal_embryo_implantation | 1.53332313 |
| 44 | MP0008995_early_reproductive_senescence | 1.52565406 |
| 45 | MP0003315_abnormal_perineum_morphology | 1.50216036 |
| 46 | MP0005499_abnormal_olfactory_system | 1.47530222 |
| 47 | MP0005394_taste/olfaction_phenotype | 1.47530222 |
| 48 | MP0005085_abnormal_gallbladder_physiolo | 1.45702206 |
| 49 | MP0000358_abnormal_cell_content/ | 1.37693553 |
| 50 | MP0003718_maternal_effect | 1.36828547 |
| 51 | MP0001293_anophthalmia | 1.36135658 |
| 52 | MP0003121_genomic_imprinting | 1.34849554 |
| 53 | MP0001440_abnormal_grooming_behavior | 1.34452235 |
| 54 | MP0005646_abnormal_pituitary_gland | 1.29251679 |
| 55 | MP0005332_abnormal_amino_acid | 1.28950394 |
| 56 | MP0005551_abnormal_eye_electrophysiolog | 1.28153930 |
| 57 | MP0008872_abnormal_physiological_respon | 1.27014676 |
| 58 | MP0003195_calcinosis | 1.25738680 |
| 59 | MP0002163_abnormal_gland_morphology | 1.25309268 |
| 60 | MP0002095_abnormal_skin_pigmentation | 1.24424933 |
| 61 | MP0002160_abnormal_reproductive_system | 1.24171351 |
| 62 | MP0000566_synostosis | 1.23961995 |
| 63 | MP0003787_abnormal_imprinting | 1.23162117 |
| 64 | MP0008007_abnormal_cellular_replicative | 1.21140622 |
| 65 | MP0005075_abnormal_melanosome_morpholog | 1.20808201 |
| 66 | MP0005266_abnormal_metabolism | 1.19674912 |
| 67 | MP0010030_abnormal_orbit_morphology | 1.18149542 |
| 68 | MP0000631_abnormal_neuroendocrine_gland | 1.17735138 |
| 69 | MP0009046_muscle_twitch | 1.17222852 |
| 70 | MP0003123_paternal_imprinting | 1.15515863 |
| 71 | MP0001663_abnormal_digestive_system | 1.13864419 |
| 72 | MP0005645_abnormal_hypothalamus_physiol | 1.13857944 |
| 73 | MP0001764_abnormal_homeostasis | 1.13339263 |
| 74 | MP0008789_abnormal_olfactory_epithelium | 1.11126739 |
| 75 | MP0005379_endocrine/exocrine_gland_phen | 1.10850331 |
| 76 | MP0002210_abnormal_sex_determination | 1.09545462 |
| 77 | MP0003646_muscle_fatigue | 1.08956003 |
| 78 | MP0003122_maternal_imprinting | 1.08534441 |
| 79 | MP0002184_abnormal_innervation | 1.07169041 |
| 80 | MP0002938_white_spotting | 1.05602227 |
| 81 | MP0003283_abnormal_digestive_organ | 1.04401026 |
| 82 | MP0003656_abnormal_erythrocyte_physiolo | 1.03933953 |
| 83 | MP0003136_yellow_coat_color | 1.03682045 |
| 84 | MP0005381_digestive/alimentary_phenotyp | 0.99665630 |
| 85 | MP0005376_homeostasis/metabolism_phenot | 0.99188913 |
| 86 | MP0002272_abnormal_nervous_system | 0.94865577 |
| 87 | MP0000751_myopathy | 0.94298015 |
| 88 | MP0001756_abnormal_urination | 0.92986375 |
| 89 | MP0004145_abnormal_muscle_electrophysio | 0.92591114 |
| 90 | MP0003567_abnormal_fetal_cardiomyocyte | 0.92470646 |
| 91 | MP0005253_abnormal_eye_physiology | 0.92310144 |
| 92 | MP0004924_abnormal_behavior | 0.91755132 |
| 93 | MP0005386_behavior/neurological_phenoty | 0.91755132 |
| 94 | MP0001664_abnormal_digestion | 0.91637849 |
| 95 | MP0009643_abnormal_urine_homeostasis | 0.91287559 |
| 96 | MP0001929_abnormal_gametogenesis | 0.91180202 |
| 97 | MP0002132_abnormal_respiratory_system | 0.90873272 |
| 98 | MP0002277_abnormal_respiratory_mucosa | 0.86920705 |
| 99 | MP0000653_abnormal_sex_gland | 0.85918957 |
| 100 | MP0001145_abnormal_male_reproductive | 0.85712518 |
| 101 | MP0009697_abnormal_copulation | 0.84777570 |
| 102 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.84271861 |
| 103 | MP0005174_abnormal_tail_pigmentation | 0.84128307 |
| 104 | MP0002653_abnormal_ependyma_morphology | 0.82324817 |
| 105 | MP0004270_analgesia | 0.81194999 |
| 106 | MP0004043_abnormal_pH_regulation | 0.80613051 |
| 107 | MP0005410_abnormal_fertilization | 0.79418264 |
| 108 | MP0004883_abnormal_blood_vessel | 0.77317308 |
| 109 | MP0000049_abnormal_middle_ear | 0.76217608 |
| 110 | MP0001919_abnormal_reproductive_system | 0.75037550 |
| 111 | MP0001188_hyperpigmentation | 0.74913844 |
| 112 | MP0006072_abnormal_retinal_apoptosis | 0.74769136 |
| 113 | MP0003011_delayed_dark_adaptation | 0.73552874 |
| 114 | MP0005423_abnormal_somatic_nervous | 0.72925665 |
| 115 | MP0003638_abnormal_response/metabolism_ | 0.71877310 |
| 116 | MP0003077_abnormal_cell_cycle | 0.71690641 |
| 117 | MP0001542_abnormal_bone_strength | 0.71660566 |
| 118 | MP0000749_muscle_degeneration | 0.71633139 |
| 119 | MP0000537_abnormal_urethra_morphology | 0.70384478 |
| 120 | MP0002332_abnormal_exercise_endurance | 0.69796107 |
| 121 | MP0002067_abnormal_sensory_capabilities | 0.69715632 |
| 122 | MP0000490_abnormal_crypts_of | 0.69338103 |
| 123 | MP0002064_seizures | 0.69232430 |
| 124 | MP0003698_abnormal_male_reproductive | 0.68335766 |
| 125 | MP0005195_abnormal_posterior_eye | 0.68100625 |
| 126 | MP0001485_abnormal_pinna_reflex | 0.68048361 |
| 127 | MP0010094_abnormal_chromosome_stability | 0.67655595 |
| 128 | MP0002876_abnormal_thyroid_physiology | 0.67621284 |
| 129 | MP0009333_abnormal_splenocyte_physiolog | 0.67435986 |
| 130 | MP0005319_abnormal_enzyme/_coenzyme | 0.66916431 |
| 131 | MP0002090_abnormal_vision | 0.66885444 |
| 132 | MP0002557_abnormal_social/conspecific_i | 0.66574406 |
| 133 | MP0002572_abnormal_emotion/affect_behav | 0.66227414 |
| 134 | MP0001286_abnormal_eye_development | 0.66211591 |
| 135 | MP0002102_abnormal_ear_morphology | 0.65447051 |
| 136 | MP0009745_abnormal_behavioral_response | 0.65184688 |
| 137 | MP0005389_reproductive_system_phenotype | 0.64488390 |
| 138 | MP0004742_abnormal_vestibular_system | 0.64487453 |
| 139 | MP0005535_abnormal_body_temperature | 0.64116050 |
| 140 | MP0005377_hearing/vestibular/ear_phenot | 0.63668899 |
| 141 | MP0003878_abnormal_ear_physiology | 0.63668899 |
| 142 | MP0002233_abnormal_nose_morphology | 0.62798261 |
| 143 | MP0000750_abnormal_muscle_regeneration | 0.62224721 |
| 144 | MP0004133_heterotaxia | 0.61962024 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 8.06893179 |
| 2 | Abnormal mitochondria in muscle tissue (HP:0008316) | 7.43715451 |
| 3 | Acute encephalopathy (HP:0006846) | 6.90674877 |
| 4 | Mitochondrial inheritance (HP:0001427) | 6.87454776 |
| 5 | Progressive macrocephaly (HP:0004481) | 6.68371950 |
| 6 | Abnormality of cells of the erythroid lineage (HP:0012130) | 6.08036129 |
| 7 | Increased CSF lactate (HP:0002490) | 5.89251661 |
| 8 | Hepatocellular necrosis (HP:0001404) | 5.76997932 |
| 9 | Cerebral edema (HP:0002181) | 5.19937537 |
| 10 | Hepatic necrosis (HP:0002605) | 5.17449653 |
| 11 | Abnormal number of erythroid precursors (HP:0012131) | 5.04764496 |
| 12 | Increased hepatocellular lipid droplets (HP:0006565) | 4.95007159 |
| 13 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 4.79131753 |
| 14 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 4.74710781 |
| 15 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 4.74710781 |
| 16 | Lipid accumulation in hepatocytes (HP:0006561) | 4.60658656 |
| 17 | Reticulocytopenia (HP:0001896) | 4.34324965 |
| 18 | Increased intramyocellular lipid droplets (HP:0012240) | 4.33574946 |
| 19 | Respiratory failure (HP:0002878) | 4.25924926 |
| 20 | Macrocytic anemia (HP:0001972) | 4.21817148 |
| 21 | Renal Fanconi syndrome (HP:0001994) | 4.14950215 |
| 22 | Exercise intolerance (HP:0003546) | 4.14130875 |
| 23 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 4.12229741 |
| 24 | Lactic acidosis (HP:0003128) | 4.06778719 |
| 25 | Abnormality of glycolysis (HP:0004366) | 4.02773333 |
| 26 | Increased serum pyruvate (HP:0003542) | 4.02773333 |
| 27 | Optic disc pallor (HP:0000543) | 3.99211962 |
| 28 | 3-Methylglutaconic aciduria (HP:0003535) | 3.93074063 |
| 29 | Leukodystrophy (HP:0002415) | 3.88046193 |
| 30 | Increased serum lactate (HP:0002151) | 3.80164934 |
| 31 | Increased muscle lipid content (HP:0009058) | 3.79107929 |
| 32 | Pallor (HP:0000980) | 3.60278752 |
| 33 | Exertional dyspnea (HP:0002875) | 3.38113843 |
| 34 | Respiratory difficulties (HP:0002880) | 2.93785500 |
| 35 | Hyperphosphaturia (HP:0003109) | 2.90573415 |
| 36 | Neuroendocrine neoplasm (HP:0100634) | 2.85738584 |
| 37 | Lethargy (HP:0001254) | 2.81849346 |
| 38 | Pheochromocytoma (HP:0002666) | 2.76192039 |
| 39 | Abnormality of renal resorption (HP:0011038) | 2.75879812 |
| 40 | Emotional lability (HP:0000712) | 2.74594183 |
| 41 | CNS demyelination (HP:0007305) | 2.62462760 |
| 42 | Abnormal hemoglobin (HP:0011902) | 2.62006829 |
| 43 | Abnormality of urine glucose concentration (HP:0011016) | 2.58508157 |
| 44 | Glycosuria (HP:0003076) | 2.58508157 |
| 45 | Conjunctival hamartoma (HP:0100780) | 2.53888852 |
| 46 | X-linked dominant inheritance (HP:0001423) | 2.48600137 |
| 47 | Congenital, generalized hypertrichosis (HP:0004540) | 2.35447047 |
| 48 | Abnormality of midbrain morphology (HP:0002418) | 2.32748601 |
| 49 | Molar tooth sign on MRI (HP:0002419) | 2.32748601 |
| 50 | Hypothermia (HP:0002045) | 2.32509009 |
| 51 | Abnormal urine phosphate concentration (HP:0012599) | 2.29253727 |
| 52 | Palpitations (HP:0001962) | 2.26714223 |
| 53 | Methylmalonic acidemia (HP:0002912) | 2.25429835 |
| 54 | Pancreatic fibrosis (HP:0100732) | 2.25052388 |
| 55 | Hyperglycinemia (HP:0002154) | 2.22969701 |
| 56 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.21071026 |
| 57 | Colon cancer (HP:0003003) | 2.17934400 |
| 58 | Pancreatic cysts (HP:0001737) | 2.17913384 |
| 59 | Abnormality of placental membranes (HP:0011409) | 2.16550162 |
| 60 | Amniotic constriction ring (HP:0009775) | 2.16550162 |
| 61 | Limb dystonia (HP:0002451) | 2.11347430 |
| 62 | Vomiting (HP:0002013) | 2.09883784 |
| 63 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.07096145 |
| 64 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.07096145 |
| 65 | Abnormal protein glycosylation (HP:0012346) | 2.07096145 |
| 66 | Abnormal glycosylation (HP:0012345) | 2.07096145 |
| 67 | Medial flaring of the eyebrow (HP:0010747) | 2.04198522 |
| 68 | Ragged-red muscle fibers (HP:0003200) | 2.00131957 |
| 69 | Multiple enchondromatosis (HP:0005701) | 2.00007239 |
| 70 | Absent thumb (HP:0009777) | 1.99683663 |
| 71 | Pancytopenia (HP:0001876) | 1.99331851 |
| 72 | Microvesicular hepatic steatosis (HP:0001414) | 1.97147746 |
| 73 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.96451737 |
| 74 | Abnormal gallbladder physiology (HP:0012438) | 1.96157577 |
| 75 | Cholecystitis (HP:0001082) | 1.96157577 |
| 76 | Poor suck (HP:0002033) | 1.95387606 |
| 77 | Gliosis (HP:0002171) | 1.94263490 |
| 78 | True hermaphroditism (HP:0010459) | 1.93055172 |
| 79 | Blindness (HP:0000618) | 1.91261261 |
| 80 | Abnormality of serum amino acid levels (HP:0003112) | 1.89822954 |
| 81 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.89154208 |
| 82 | Abnormality of alanine metabolism (HP:0010916) | 1.89154208 |
| 83 | Hyperalaninemia (HP:0003348) | 1.89154208 |
| 84 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.88728190 |
| 85 | Oral leukoplakia (HP:0002745) | 1.88427733 |
| 86 | Reduced antithrombin III activity (HP:0001976) | 1.88149640 |
| 87 | Abnormality of methionine metabolism (HP:0010901) | 1.87294603 |
| 88 | Dicarboxylic aciduria (HP:0003215) | 1.87246708 |
| 89 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.87246708 |
| 90 | Neoplasm of head and neck (HP:0012288) | 1.85985747 |
| 91 | Esophageal neoplasm (HP:0100751) | 1.85985747 |
| 92 | Aplastic anemia (HP:0001915) | 1.84712232 |
| 93 | Degeneration of anterior horn cells (HP:0002398) | 1.84698633 |
| 94 | Abnormality of the anterior horn cell (HP:0006802) | 1.84698633 |
| 95 | Cleft eyelid (HP:0000625) | 1.80831028 |
| 96 | Abnormal pupillary function (HP:0007686) | 1.80358458 |
| 97 | Abnormality of the vocal cords (HP:0008777) | 1.79099140 |
| 98 | Sclerocornea (HP:0000647) | 1.78586932 |
| 99 | Abnormality of the labia minora (HP:0012880) | 1.77633932 |
| 100 | Triphalangeal thumb (HP:0001199) | 1.76749894 |
| 101 | Abnormality of reticulocytes (HP:0004312) | 1.74801183 |
| 102 | Renal tubular dysfunction (HP:0000124) | 1.73852933 |
| 103 | Megaloblastic anemia (HP:0001889) | 1.69963848 |
| 104 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.68307694 |
| 105 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.67197083 |
| 106 | Gait imbalance (HP:0002141) | 1.62642497 |
| 107 | Congenital primary aphakia (HP:0007707) | 1.61484676 |
| 108 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.60800934 |
| 109 | Nephronophthisis (HP:0000090) | 1.59939114 |
| 110 | Abnormality of magnesium homeostasis (HP:0004921) | 1.59277170 |
| 111 | Testicular atrophy (HP:0000029) | 1.57549312 |
| 112 | Hyperglycinuria (HP:0003108) | 1.56333401 |
| 113 | Neoplasm of the adrenal gland (HP:0100631) | 1.54038737 |
| 114 | Methylmalonic aciduria (HP:0012120) | 1.54037467 |
| 115 | Nausea (HP:0002018) | 1.52130196 |
| 116 | Hypobetalipoproteinemia (HP:0003563) | 1.49537338 |
| 117 | Progressive external ophthalmoplegia (HP:0000590) | 1.48095620 |
| 118 | * Myokymia (HP:0002411) | 1.47567186 |
| 119 | Trismus (HP:0000211) | 1.47093805 |
| 120 | Carpal bone hypoplasia (HP:0001498) | 1.44849240 |
| 121 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.42198680 |
| 122 | Hypokinesia (HP:0002375) | 1.42147906 |
| 123 | Angiofibromas (HP:0010615) | 1.40686931 |
| 124 | Adenoma sebaceum (HP:0009720) | 1.40686931 |
| 125 | Type I transferrin isoform profile (HP:0003642) | 1.39518697 |
| 126 | Delusions (HP:0000746) | 1.38960016 |
| 127 | Generalized aminoaciduria (HP:0002909) | 1.38922998 |
| 128 | Depressed nasal ridge (HP:0000457) | 1.37713619 |
| 129 | Microretrognathia (HP:0000308) | 1.37345322 |
| 130 | Cerebral hypomyelination (HP:0006808) | 1.36604837 |
| 131 | Rhabdomyolysis (HP:0003201) | 1.36431457 |
| 132 | Stenosis of the external auditory canal (HP:0000402) | 1.35192764 |
| 133 | Abnormal autonomic nervous system physiology (HP:0012332) | 1.33329248 |
| 134 | Orthostatic hypotension (HP:0001278) | 1.33029513 |
| 135 | Metabolic acidosis (HP:0001942) | 1.30173536 |
| 136 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.29546051 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 5.84670113 |
| 2 | VRK2 | 5.20066492 |
| 3 | STK16 | 3.49885848 |
| 4 | LIMK1 | 3.28382047 |
| 5 | NME1 | 3.26801118 |
| 6 | MAP3K12 | 3.19097887 |
| 7 | ARAF | 2.98850496 |
| 8 | BUB1 | 2.90450453 |
| 9 | PIM2 | 2.55937691 |
| 10 | TESK2 | 2.50118233 |
| 11 | TLK1 | 2.49138695 |
| 12 | ZAK | 2.39262643 |
| 13 | GRK5 | 2.36717386 |
| 14 | EIF2AK1 | 2.27287939 |
| 15 | TESK1 | 2.25249352 |
| 16 | VRK1 | 2.12920095 |
| 17 | NUAK1 | 1.92594625 |
| 18 | MYLK | 1.92235471 |
| 19 | WEE1 | 1.85425363 |
| 20 | PBK | 1.74253986 |
| 21 | MST4 | 1.66864688 |
| 22 | BCKDK | 1.64237319 |
| 23 | BRAF | 1.58687439 |
| 24 | NEK1 | 1.56790693 |
| 25 | ILK | 1.46750602 |
| 26 | PLK4 | 1.39741200 |
| 27 | ABL2 | 1.38156453 |
| 28 | PDK2 | 1.34076169 |
| 29 | TAF1 | 1.31978129 |
| 30 | TTK | 1.29756708 |
| 31 | EIF2AK3 | 1.23720196 |
| 32 | AURKA | 1.22966761 |
| 33 | MAP4K2 | 1.22641894 |
| 34 | DAPK3 | 1.18902505 |
| 35 | SRPK1 | 1.17055535 |
| 36 | UHMK1 | 1.16405211 |
| 37 | GRK7 | 1.09384317 |
| 38 | WNK4 | 1.08649135 |
| 39 | ADRBK2 | 1.06378167 |
| 40 | CASK | 1.06102729 |
| 41 | DYRK2 | 1.05977318 |
| 42 | LRRK2 | 1.05258353 |
| 43 | CCNB1 | 1.01581858 |
| 44 | RPS6KB2 | 0.95321338 |
| 45 | GRK1 | 0.95029766 |
| 46 | TRIM28 | 0.94856741 |
| 47 | ADRBK1 | 0.94819689 |
| 48 | CHEK2 | 0.94296249 |
| 49 | GRK6 | 0.93222298 |
| 50 | CDK8 | 0.91998461 |
| 51 | CSNK1G1 | 0.89177228 |
| 52 | CSNK1G2 | 0.88957948 |
| 53 | MAP2K2 | 0.88619433 |
| 54 | PAK1 | 0.85119532 |
| 55 | BMPR1B | 0.84131644 |
| 56 | MST1R | 0.83854991 |
| 57 | DAPK1 | 0.83657432 |
| 58 | MAP3K11 | 0.83435650 |
| 59 | MAPKAPK5 | 0.83370574 |
| 60 | CDK19 | 0.82059743 |
| 61 | CSNK1G3 | 0.79563774 |
| 62 | ATR | 0.78194679 |
| 63 | MKNK1 | 0.77519629 |
| 64 | CDK14 | 0.74559877 |
| 65 | PAK4 | 0.72980416 |
| 66 | AURKB | 0.72461627 |
| 67 | CSNK2A1 | 0.69728917 |
| 68 | CSNK2A2 | 0.69409021 |
| 69 | CAMK2B | 0.67754294 |
| 70 | CDC7 | 0.66180598 |
| 71 | CDK18 | 0.65649829 |
| 72 | MAPKAPK3 | 0.65543745 |
| 73 | CSNK1A1L | 0.65137598 |
| 74 | MINK1 | 0.64999432 |
| 75 | CAMK2D | 0.63684389 |
| 76 | CDK15 | 0.63648883 |
| 77 | CDK11A | 0.62864976 |
| 78 | MAPK13 | 0.61659105 |
| 79 | MAP2K7 | 0.61381266 |
| 80 | PRKCG | 0.61072507 |
| 81 | CAMK2G | 0.60545150 |
| 82 | MAP3K4 | 0.59772312 |
| 83 | PHKG2 | 0.59759480 |
| 84 | PHKG1 | 0.59759480 |
| 85 | TAOK3 | 0.59446213 |
| 86 | PLK1 | 0.59111643 |
| 87 | WNK3 | 0.57958885 |
| 88 | ACVR1B | 0.55760304 |
| 89 | MAP2K6 | 0.55267269 |
| 90 | BRSK2 | 0.54813026 |
| 91 | PRKCI | 0.53565358 |
| 92 | RPS6KA4 | 0.53040566 |
| 93 | STK39 | 0.52973570 |
| 94 | NEK2 | 0.52945428 |
| 95 | EIF2AK2 | 0.52487742 |
| 96 | OXSR1 | 0.51455703 |
| 97 | INSRR | 0.51317323 |
| 98 | KDR | 0.50045600 |
| 99 | CAMKK2 | 0.49313594 |
| 100 | TSSK6 | 0.48517157 |
| 101 | FLT3 | 0.48423614 |
| 102 | PINK1 | 0.47945973 |
| 103 | BRSK1 | 0.47446682 |
| 104 | OBSCN | 0.47416622 |
| 105 | SCYL2 | 0.47170691 |
| 106 | LMTK2 | 0.46467961 |
| 107 | PRKG2 | 0.45958568 |
| 108 | PLK2 | 0.45146027 |
| 109 | MAPK4 | 0.43049895 |
| 110 | RPS6KA5 | 0.42736311 |
| 111 | TGFBR1 | 0.42210960 |
| 112 | CSNK1E | 0.42105836 |
| 113 | ROCK2 | 0.41842114 |
| 114 | MUSK | 0.41424844 |
| 115 | MAP2K1 | 0.39470737 |
| 116 | PLK3 | 0.39178979 |
| 117 | DYRK3 | 0.37829231 |
| 118 | EPHA4 | 0.36978970 |
| 119 | MATK | 0.36762784 |
| 120 | ATM | 0.36730250 |
| 121 | PRKACA | 0.36423409 |
| 122 | CDK7 | 0.36343389 |
| 123 | CSNK1A1 | 0.36078038 |
| 124 | KSR2 | 0.35558765 |
| 125 | RPS6KC1 | 0.34579328 |
| 126 | RPS6KL1 | 0.34579328 |
| 127 | CDK3 | 0.33597980 |
| 128 | ERBB3 | 0.33513876 |
| 129 | MAP3K8 | 0.32732014 |
| 130 | EPHB2 | 0.32609822 |
| 131 | PIK3CG | 0.32279461 |
| 132 | MARK1 | 0.31620251 |
| 133 | CAMK2A | 0.31221486 |
| 134 | BCR | 0.29479255 |
| 135 | PASK | 0.29386518 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 6.12518921 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 5.51831093 |
| 3 | Parkinsons disease_Homo sapiens_hsa05012 | 5.47246274 |
| 4 | Alzheimers disease_Homo sapiens_hsa05010 | 3.90667165 |
| 5 | Huntingtons disease_Homo sapiens_hsa05016 | 3.82638914 |
| 6 | Proteasome_Homo sapiens_hsa03050 | 3.61904694 |
| 7 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 3.42533496 |
| 8 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.38448347 |
| 9 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.27204688 |
| 10 | Protein export_Homo sapiens_hsa03060 | 2.13944664 |
| 11 | RNA polymerase_Homo sapiens_hsa03020 | 2.07769956 |
| 12 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.82003788 |
| 13 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.74511353 |
| 14 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.72912220 |
| 15 | DNA replication_Homo sapiens_hsa03030 | 1.72211428 |
| 16 | Mismatch repair_Homo sapiens_hsa03430 | 1.40321268 |
| 17 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.34991507 |
| 18 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.28728065 |
| 19 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.27130495 |
| 20 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.25383689 |
| 21 | Sulfur relay system_Homo sapiens_hsa04122 | 1.23780577 |
| 22 | Spliceosome_Homo sapiens_hsa03040 | 1.20998941 |
| 23 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.19248075 |
| 24 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.15290279 |
| 25 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.13467034 |
| 26 | Carbon metabolism_Homo sapiens_hsa01200 | 1.10746429 |
| 27 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.09838784 |
| 28 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.02782975 |
| 29 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.99365137 |
| 30 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.97137268 |
| 31 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.94849014 |
| 32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.93802779 |
| 33 | Homologous recombination_Homo sapiens_hsa03440 | 0.93700217 |
| 34 | Metabolic pathways_Homo sapiens_hsa01100 | 0.89889881 |
| 35 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.89885701 |
| 36 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.89085436 |
| 37 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.89073892 |
| 38 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.88144063 |
| 39 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.86911858 |
| 40 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.82306257 |
| 41 | Purine metabolism_Homo sapiens_hsa00230 | 0.81317097 |
| 42 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.81200078 |
| 43 | Base excision repair_Homo sapiens_hsa03410 | 0.79762564 |
| 44 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.77790600 |
| 45 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.77271593 |
| 46 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.76307095 |
| 47 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.75206711 |
| 48 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.71844068 |
| 49 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.70183968 |
| 50 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.70170174 |
| 51 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.69743024 |
| 52 | Asthma_Homo sapiens_hsa05310 | 0.67905497 |
| 53 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.67809826 |
| 54 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.67040749 |
| 55 | Phototransduction_Homo sapiens_hsa04744 | 0.67027590 |
| 56 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.66986946 |
| 57 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.66484567 |
| 58 | RNA transport_Homo sapiens_hsa03013 | 0.65581581 |
| 59 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.64070536 |
| 60 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.63739470 |
| 61 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.63385678 |
| 62 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.63082402 |
| 63 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.63048943 |
| 64 | Peroxisome_Homo sapiens_hsa04146 | 0.60419343 |
| 65 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.59614004 |
| 66 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.59279526 |
| 67 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.58997668 |
| 68 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.57079352 |
| 69 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.56882013 |
| 70 | Histidine metabolism_Homo sapiens_hsa00340 | 0.52641016 |
| 71 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.51546319 |
| 72 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.46517927 |
| 73 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.45947155 |
| 74 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.44847922 |
| 75 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.42046654 |
| 76 | Alcoholism_Homo sapiens_hsa05034 | 0.41705362 |
| 77 | Phagosome_Homo sapiens_hsa04145 | 0.38405786 |
| 78 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.38235617 |
| 79 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.36855702 |
| 80 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.36771770 |
| 81 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.36666592 |
| 82 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.35667680 |
| 83 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.35341073 |
| 84 | Nicotine addiction_Homo sapiens_hsa05033 | 0.35314629 |
| 85 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.35155958 |
| 86 | Basal transcription factors_Homo sapiens_hsa03022 | 0.34692770 |
| 87 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.34108243 |
| 88 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.32135515 |
| 89 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.31386560 |
| 90 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.30256067 |
| 91 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.30250386 |
| 92 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.30197446 |
| 93 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.30099752 |
| 94 | RNA degradation_Homo sapiens_hsa03018 | 0.29351546 |
| 95 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.29010056 |
| 96 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.28793658 |
| 97 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.28588284 |
| 98 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.27741439 |
| 99 | Galactose metabolism_Homo sapiens_hsa00052 | 0.26259582 |
| 100 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.25116507 |
| 101 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.24292931 |
| 102 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.24133444 |
| 103 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.23368473 |
| 104 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.21942362 |
| 105 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.21530619 |
| 106 | Mineral absorption_Homo sapiens_hsa04978 | 0.18763419 |
| 107 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.17689786 |
| 108 | Retinol metabolism_Homo sapiens_hsa00830 | 0.17606239 |
| 109 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.16381292 |
| 110 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.11103825 |
| 111 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.11023560 |
| 112 | Cell cycle_Homo sapiens_hsa04110 | 0.10974929 |
| 113 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.10926308 |
| 114 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.10852750 |
| 115 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.10520596 |
| 116 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.10485049 |
| 117 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.10329600 |
| 118 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.06315255 |
| 119 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.05078279 |
| 120 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.02482235 |
| 121 | Taste transduction_Homo sapiens_hsa04742 | 0.02421846 |

